BALY Earnings

BALY reported its earnings on 2026-02-26, showcasing a revenue of against an estimate of 629.40M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.92 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following BALY's earnings announcement on 2026-02-26, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, BALY's stock price tends to shift by an average of +5.24% in the 10 days leading up to earnings and +5.46% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate BALY’s annual revenue to reach 671.77M, while the EPS is projected at -0.70. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 1.49% and EPS estimates Revise Upward by 4.32% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between BALY's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 1.49%, while EPS estimates moved Revise Upward by 4.32% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, BALY's stock price typically moves by +5.24% in the 10 days before its earnings and +5.46% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.70 and revenue of 671.77M.

The earnings call reveals a mixed picture. While there are growth initiatives and strategic expansions, the financial performance is underwhelming, with a decline in revenue and EBITDA in key segments. The heavy debt load and lack of a share repurchase program further weigh on sentiment. Despite some positive developments, such as the merger and expansion plans, the financial risks, operational challenges, and regulatory uncertainties present a negative outlook for the stock price in the short term.